YONOSTERYL
Active material: sodium chloride, potassium acetate, sodium acetate, calcium acetate, Magna aspartate
When ATH: B05BB
CCF: Preparation for rehydration and detoxification for parenteral use
When CSF: 21.06.02
Manufacturer: FRESENIUS KABI GERMANY GmbH (Germany)
Pharmaceutical form, composition and packaging
Solution for infusion clear, colorless.
| 1 l | |
| sodium chloride | 6.43 g |
| potassium acetate | 393 mg |
| sodium acetate | 3.674 g |
| calcium acetate | 261 mg |
| Magna aspartate bezvodnыy | 261 mg |
| Equivalent to content: | |
| On+ | 137 mmol / l |
| Ca2+ | 1.65 mmol / l |
| Cl– | 110 mmol / l |
| K+ | 4 mmol / l |
| Mg2+ | 1.25 mmol / l |
| CH3COO– | 36.8 mmol / l |
| pH 5.0-7.0 titratable acidity 1-10 mmol NaOH/l osmolarity 291 mOsm / l | |
500 ml – plastic bottles “Kabi Pack” (10) – packs cardboard.
Pharmacological action
Plazmozameshchath means.
Testimony
Extracellular (isotonic) Dehydration of various origins: diarrhea, vomiting, CVIS, drainage, ileus; primary replacement of plasma in the blood loss and burns.
Contraindications
Hypersensitivity, swelling, hypertonic dehydration, CRF.
Side effects
Swelling. Tachycardia.
Dosing and Administration
B / continuous drip infusion at a dose of 0.5 to 1 l / day or more. The drug is administered at a rate of 70 drops / min or 210 ml / h at the patient's body weight 70 kg. If necessary, may increase the dose and rate of administration to 500 ml for 15 m.
